- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT04066205
Sleep Self-Management Intervention for Children With Juvenile Idiopathic Arthritis (SLEEPSMART)
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
To develop and test a technology-based sleep self-management intervention delivered to 9-to-11 year-old children with JIA and their parents. The initial feasibility, acceptability, and efficacy of the newly developed sleep self-management intervention will be tested in a pilot randomized controlled trial comparing the active intervention against standard care with a sample of 60 children with JIA and their parents. Sleep will be measured using actigraphy, sleep diaries, & self-report measures. Problem-solving skills, motivation, beliefs about sleep, and sleep self-efficacy will be measured before and after the intervention. The long-term goal is to develop effective and low cost treatments to reduce sleep deficiency and the sleep-related health consequences among children with JIA. The specific aims are to:
Aim 1. Apply a user-centered design approach to develop and refine a technology-based sleep self-management intervention (SLEEPSMART). Direct stakeholder input will be obtained from children and parents about their needs for sleep shared-management as well as intervention material from our prior Web-based interventions for youth with chronic pain that includes sleep hygiene education, and a self-management focus (motivation, self-efficacy, patient activation) to develop content for the SLEEPSMART. Qualitative methods (iterative cycles of semi-structured audiotaped sessions with children and parents and think-aloud observation sessions by a trained observer) will be used to evaluate the usability of the SLEEPSMART prototype. Results of these analyses will guide program finalization.
Aim 2. Determine feasibility and initial efficacy of the SLEEPSMART with children with JIA in a pilot RCT. Study accrual and dropout rates will be assessed, as well as, levels of patient acceptability and engagement in a pilot randomized controlled trial (RCT) comparing usual care to SLEEPSMART intervention. Preliminary effect sizes of the SLEEPSMART will be determined in youth receiving treatment compared to usual care on primary outcomes of actigraphy sleep duration, sleep quality, and feasibility/acceptability, and secondary outcomes of child and parent self-management(activation, motivation, self-efficacy), technology use, recommendations for innovative sleep monitoring
Studientyp
Einschreibung (Tatsächlich)
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
Washington
-
Seattle, Washington, Vereinigte Staaten, 98195
- University of Washington School of Nursing
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria for Children:
- diagnosed with JIA
- 8-13 years
- able to read/speak English
- parent report that child has difficulties with sleep quality (difficulty falling asleep, no bedtime routine, waking up in the middle of the night and struggling to fall back asleep) and/or poor sleep impacts their child's day to day function (school, interacting with peers, hobbies).
Inclusion criteria for parents:
- > 18 years
- able to read/speak English.
Exclusion Criteria for Children:
- currently receiving
- lack of daily access to the Internet or mobile device as the study will be conducted online
- developmental delay
- child is not currently participating in psychological therapy.
Exclusion criteria for parents:
- diagnosed with a chronic illness that would interfere with ability to complete study procedures
- lack of daily access to the Internet or mobile device.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Verhütung
- Zuteilung: N / A
- Interventionsmodell: Einzelgruppenzuweisung
- Maskierung: Keine (Offenes Etikett)
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
---|---|
Experimental: SLEEPSMART PROGRAM
Arm: Placebo Comparator (Usual care)-This treatment arm will receive usual JIA care, including annual Rheumatology clinic visits, medications, routine clinical and laboratory tests, physical therapy, follow-up appointments, and no sleep intervention. Arm: Experimental -Each child and parent will create a login, choose treatment goals, and interact with fields in the Web site. The modules will focus on improving sleep hygiene, relaxation, or increasing sleep duration. The intervention will last 6 to 8 weeks. |
SLEEPSMART will be designed to improve sleep by providing guidance and structure to assist JIA children and their parent in adhering to the intervention protocol.
The intervention will be interactive and personalized; users will interface with three primary components:1) monitoring: daily records of sleep and symptoms; 2) skill building modules: sleep education, sleep skills training, relaxation techniques, positive coping skills, and reward systems for activity participation for reducing sleep deficiency; and 3) assignment review and personalized feedback via behavioral assignments for skill implementation and tailored feedback.
Modules will take an estimated 30 minutes each week to complete and will include multimedia elements to enhance learning.
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
sleep quality
Zeitfenster: change from baseline (start of the study); 2 months (immediately after the intervention), and 3 months (study completion)
|
Child Sleep Hygiene Scale- overall sleep hygiene score; 6-point scale; higher scores indicate better sleep hygiene.
|
change from baseline (start of the study); 2 months (immediately after the intervention), and 3 months (study completion)
|
self-efficacy
Zeitfenster: change from baseline (start of the study); 2 months (immediately after the intervention) and 3 months (study completion)
|
Self-Efficacy scale: 9-item self-report of confidence in carrying out sleep-related behaviors; Likert scale from 1 (not at all confident) to 10 (totally confident); higher score indicates better self-efficacy.
|
change from baseline (start of the study); 2 months (immediately after the intervention) and 3 months (study completion)
|
Usability of SLEEPSMART
Zeitfenster: 3 months at study completion
|
Semi-structured interviews will be conducted to assess their overall child and parent perceptions of the web-based program, the perceived usefulness and ease of use.
|
3 months at study completion
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
sleep duration
Zeitfenster: change from baseline (start of the study); 2 months (immediately after the intervention) and 3 months (study completion)
|
actigraphy total sleep time
|
change from baseline (start of the study); 2 months (immediately after the intervention) and 3 months (study completion)
|
acceptability of SLEEPSMART
Zeitfenster: 3 months at study completion
|
Parent and child survey about the likes and dislikes of the study protocol, areas for improvement, SLEEPSMART program and weekly assignments
|
3 months at study completion
|
Mitarbeiter und Ermittler
Sponsor
Mitarbeiter
Ermittler
- Hauptermittler: Teresa M Ward, RN, PhD, University of Washington
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Tatsächlich)
Studienabschluss (Tatsächlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- STUDY00005070
- R21NR017471-01A1 (US NIH Stipendium/Vertrag)
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Produkt, das in den USA hergestellt und aus den USA exportiert wird
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Juvenile idiopathische Arthritis
-
Istituto Giannina GasliniPfizer; Agenzia Italiana del Farmaco; Compagnia di San PaoloRekrutierungOligoarthritis, juvenil | Polyarthritis, juvenil, Rheumafaktor negativItalien
-
University College London HospitalsRekrutierungArthritis, juvenile idiopathische | Enthesitis-assoziierte Arthritis, juvenilVereinigtes Königreich
-
PfizerNoch keine RekrutierungPolyartikuläre juvenile idiopathische Arthritis | Psoriasis-Arthritis, juvenilKorea, Republik von
-
National Institute of Arthritis and Musculoskeletal...Children's Hospital Medical Center, CincinnatiAbgeschlossenJuvenile rheumatoide ArthritisVereinigte Staaten
-
University of PittsburghNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)AbgeschlossenRheumatoide Arthritis | Juvenile rheumatoide ArthritisVereinigte Staaten
-
University of Missouri-ColumbiaAbgeschlossenJuvenile rheumatoide ArthritisVereinigte Staaten
-
DePuy OrthopaedicsAbgeschlossenArthrose | Rheumatoide Arthritis | Posttraumatische Arthritis | Juvenile ArthritisVereinigte Staaten
-
Michael Rapoff, Ph.D.Abgeschlossen
-
AmgenBeendetJuvenile rheumatoide Arthritis
-
Children's Hospital Medical Center, CincinnatiNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)AbgeschlossenJuvenile rheumatoide ArthritisVereinigte Staaten